GlassScriptPhysician profile
Gregory J Mishkel
NPI 1629150768
$45,059.16
in general payments reported to CMS, 2019-2025
19 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,812 · 2020: $558 · 2021: $1,644 · 2022: $13K · 2023: $19K · 2024: $8,037 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,013 · Food and Beverage: $2,251 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,637.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,012.50 |
| Food and Beverage | $2,250.96 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $26,696.04 | 2019-2024 | Ffrct |
| Siemens Medical Solutions USA, INC. | $12,140.87 | 2020-2024 | Naeotom Alpha, Somatom Force, Magnetom Sola |
| Boston Scientific Corporation | $3,206.57 | 2019-2023 | |
| Abbott Laboratories | $870.70 | 2019-2025 | Coroflow, Cardiomems |
| Ge Healthcare | $530.97 | 2023-2025 | |
| Shockwave Medical, INC | $325.07 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $316.62 | 2019-2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $291.68 | 2024-2025 | Repatha |
| Medtronic, INC. | $186.46 | 2023-2024 | Linq II, Selectsecure, Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $180.41 | 2020-2023 | |
| Medtronic Vascular, INC. | $60.96 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $59.88 | 2024 | Uptravi |
| Akcea Therapeutics, INC. | $52.33 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.78 | 2019-2025 | Jardiance |
| Abiomed | $34.19 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.10 | 2024 | Camzyos |
| Lsi Solutions INC | $16.70 | 2024 | Cor-Knot |
| Janssen Pharmaceuticals, INC | $16.52 | 2025 | Uptravi |
| Astrazeneca Pharmaceuticals LP | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mishkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.